ESR1 and breast cancer: In prostate and breast cancer cells, Pang et al. observed that the diethyldithiocarbamate (DDTC)-copper complex suppressed proteasomal chemotrypsin-like activity, reduced various oncogenes, including androgen receptor (AR), estrogen receptor (ER) α and ERβ proteins, and finally induced apoptosis [36].